Non-Profit Research Finds MDMA Therapeutic for PTSD Patients

Getty Images


Anyone who's ever tried ecstasy and found themselves word vomiting their complete adoration for their friends, their long-held silent fears, and their deepest inner musings knows MDMA is a primo recipe for opening up. Science, however, can not take ecstasy at a party. Science has to go about these things methodically.

New research from the California-based non profit Multidisciplinary Association for Psychedelic Studies (MAPS) has found, scientifically, that MDMA is very effective for patients suffering from Post-Traumatic Stress Disorder, or PTSD. Researchers treated 107 PTSD patients with controlled MDMA consumption and concurrent therapy sessions with a mental health counselor. After a year of treatment, 67 percent those who underwent two to three MDMA treatment sessions reported that they no longer suffered from PTSD-related symptoms, while 23 percent of subject given placebos reported the same results.

According to MAPS, pure MDMA has been found safe for human consumption in laboratory studies and has proven to help heal the emotional damage of those suffering from sexual assault, war, violent crime, and other traumatic events. MAPS makes clear on its website that MDMA is not the same as “ecstasy,” “molly” and other known street drugs which combine MDMA with other, more dangerous substances.

MAPS is also dedicated to putting about $25 million toward lobbying the Food and Drug Administration to approve MDMA as a prescription medication by 2021. Only time will tell whether or not pure MDMA is coming to a therapist's office near you.


The Biz premium subscriber content has moved to

To simplify subscriber access, we have temporarily disabled the password requirement.